Latest News
Xybion Completes Acquisition of Stelex, a Leader in Business Process Improvement Software and Consulting Services and Vital-Path, a leader in Enterprise Content Management from GE Healthcare.
Acquisition Extends Consulting and Implementation Capabilities and Software Offerings of Xybion Corporation.
Cedar Knolls, NJ, May 10, 2010 - Xybion Corporation announced today that it has completed the acquisition of substantially all of the operating assets of Stelex and Vital-Path from GE Healthcare. The terms of the transactions were not disclosed.
Stelex and Vital-Path, based in Bensalem, PA is a strategic addition to Xybion’s enterprise software and consulting solutions focus for the life sciences, finance, manufacturing and other regulated industries. Stelex and Vital-Path provide a range of products and services to regulated industries.
- Asset and Facilities Management solutions including services and support for IBM’s Maximo, a leading software solution that enables the user to develop comprehensive programs for preventive, predictive, routine and unplanned maintenance for assets and facilities
- Enterprise Content Management and Migration solutions to assist clients in taking control of their mission critical content and to seamlessly share data among disparate departmental content repositories
- Regulatory Compliance solutions and System integration and implementation services for regulated industries.
The acquisition will extend Xybion’s software, consulting and Implementation capabilities and increase the company’s enterprise client base.
“The addition of Stelex and Vital-Path will advance Xybion’s vision of being the enterprise system partner of choice for life sciences product companies and CROs worldwide,” said Dr. Pradip K. Banerjee, Chairman and CEO of Xybion Corporation. “Stelex’s solutions, talent and customers enhance Xybion’s business and extend our ability to deliver compelling products and services to enterprise customers. Stelex’s reputation in quality assurance and validation consulting for the pharmaceutical and life science industry is unparalleled. In addition, their experience and positioning with partners like IBM and OpenText complement Xybion’s expansion into other markets with a focus on business process and quality management improvements in both regulated and non-regulated industries”.
“This is an exciting milestone for our company, and we look forward to scaling our growth as part of Xybion,” said Tony Kashani, president of Stelex. “Xybion’s global reach, widely recognized brand and customer relationships make an ideal fit for Stelex. Like Xybion, we have our roots in the life sciences and have expanded our opportunities with offerings in other markets. Our combined teams will create exciting growth opportunities for both of our customers and our employees. We look forward to working with the Xybion team to ensure a rapid and seamless transition.”
Stelex’s Bensalem, PA office will function as Xybion’s Center of Excellence for the Xybion consulting and Implementation business. The acquisition more than doubles Xybion’s size and adds significant staff capabilities in development, sales and marketing for Xybion. Xybion currently has offices in the United States, Canada, and Europe.
About Xybion
Xybion is the enterprise system partner of choice for life sciences product companies and research organizations worldwide for end-to-end needs in the pre-clinical R&D, Quality, and Regulatory risk and compliance management solutions. In addition to Pristima™, Pristima™ VM, Providence®, eQRP®, and eQCM®, Xybion also provides professional services, consulting, training and validation activities to clients around the world. Learn more about Xybion athttp://www.xybion.com.
About Stelex
For over twenty years, Stelex has provided solutions and services to improve business processes for regulated and non-regulated industries, by providing the expertise, strategies and technology to help clients mitigate risk, enhance productivity and increase profitability. Stelex is a client-centered organization, tailoring solutions to address the specific requests and needs of clients. Stelex assists clients in meeting requirements and achieving their business goals. Learn more about Stelex at http://www.stelex.com.
###
Media Contacts:
Pradip Banerjee
media@xybion.com
(973) 538-5111
Xybion Completes Acquisition of Amadeus, a Leader in Governance, Risk, Compliance and Quality Management (GRC) Solutions for the Life Sciences, Manufacturing, and Financial Services Industries
Amadeus will operate as a division of Xybion Corporation.
Cedar Knolls, NJ December 1, 2009 - Xybion Corporation announced today that through the creation of a wholly owned Quebec Corporation, Services Informatiques Xybion, it has completed the acquisition of all operating assets of Quebec City based Amadeus Solutions, a leader in the development of enterprise governance, risk, compliance and quality management software solutions, from Decimal Technologies, a corporate performance management organization headquartered in Montreal.
Amadeus has been partnering with organizations in life sciences, manufacturing, finance and government sectors to manage risk, quality and compliance by automating processes such as corrective and preventive actions, non-conformance and defects, complaints management, audits, training and SOP management, incident management, programs and project management, vendor management, document management and corporate governance and other related quality and business processes. The Amadeus’s eQCM® software platform is a powerful web-based solution that enables organizations to comply with requirements stemming from FDA,ISO and other regulatory standards like GxP, FDA 21 CFR Part 11, ISO 9001, ISO14001, financial reporting and governance regulations Sarbens-Oxley, Canada Bill 198, and other industry standards and risk-based regulations. eQCM® is designed for maximum flexibility and easy adaptation to an organizations unique Governance, Compliance & Risk management (GRC) processes. eQCM® is also coupled with powerful business intelligence capabilities, enterprise content management , and related technologies that help organizations achieve sustained compliance and improve process performance. Amadeus’s solutions have been implemented at 130 companies in North America and Europe.
“Amadeus further strengthens our holistic strategic approach to delivering enterprise solutions to our life science and medical research partners. Combining Xybion’s more than 30 years of experience in providing software solutions to global pharmaceutical, CRO and life science companies through it’s Pristima and Pristima VM platforms, Amedeus’s GRC platform will offer our partner companies a single partner for their enterprise needs in the regulated environment.” said Dr. Pradip K. Banerjee, Chairman and CEO of Xybion Corporation. “By leveraging the strengths of our different divisions and staff, and working with our customers in thirteen countries, we are able to provide solutions that no other company can match today”, said Michael Tucker, a veteran of the life science and process management software industries who has been appointed as Vice President and General Manager of Amadeus.
“Initially, we were searching for a partner to help penetrate the US and European life sciences market with the Amadeus solutions,” remarked Stéphane Gaouette, president of DECIMAL, “but in the course of our discussions it became evident that with strategic vision and direction of Xybion Amadeus will be in a better position for the future as a Xybion company.” While Amadeus will be a wholly owned division of Xybion Corporation, DECIMAL will retain a position on the board of directors of Amadeus business to continue to provide guidance and insight for product and market growth. DECIMAL will also be a partner with Xybion, retaining exclusive rights in Quebec for distribution of Amadeus’ Internal Controls Manager (ICM) product.
All of the employees of Amadeus have been retained by Services Informatiques Xybion. The Quebec City office will function as Xybion’s center of Excellence for the GRC business.
About Xybion
Xybion is the enterprise system partner of choice for life sciences product companies and research organizations worldwide for end-to end needs in the pre-clinical R&D, Quality, Regulatory risk and compliance management solutions. In addition to Pristima™, and Pristima™ VM, Providence®, eQRP®, eQCM®, Xybion provides professional services, consulting, training and validation activities to clients around the world. (http://xybion.com).
About Amadeus
Amadeus, a division of Xybion, is a leading provider of Enterprise Quality and Compliance Management software solutions. For over 14 years, customers in the Life Sciences, Manufacturing, Financial Services and other industries have automated their compliance and quality processes using Amadeus software platforms. Its flagship product, eQCM, offers an integrated and very cost effective solution for enterprise governance, risk management, quality and compliance management. (http://amadeussolutions.com)
About DECIMAL
DECIMAL, the leader in corporate performance management (CPM) and in governance, risk, quality and compliance management (GRC), provides private, public and paragovernmental organizations, for nearly twenty years, with consulting services and software solutions. DECIMAL improves corporate performance by providing all decision-makers with all required financial information to better understand their costs, their profitability, optimize their budget and provide sound governance.
Xybion Unveils Pristima™ VM
An Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management.
Cedar Knolls, NJ November 11, 2009
Xybion Medical Systems announced today that it has unveiled Pristima(TM) VM, an integrated enterprise software solution for research facilities that track the use and care of veterinary research subjects. Pristima(TM) VM has been engineered to operate either stand alone or, more importantly, as an integrated solution with Xybion's core Pristima(TM) product that is in use in many of the world's premier pharmaceutical, contract research organization (CRO) and chemical research facilities that conduct product safety testing and research.
The integration of Pristima(TM) VM with the Pristima(TM) preclinical solution is a completely new way of thinking for vendors in this industry. This solution is filling a market void that the industry has been pressing vendors to address. Applications on the market today address only the animal management side of the business or the safety testing toxicology and pathology side of product research and development, leaving critical gaps in the flow of information for pharmaceutical, CRO or other research organizations. Xybion has now closed that gap and provided something that no other vendor has been able to, a conduit between the business, animal management and scientific aspects of research.
Pristima(TM) VM will be publicly debuted at the American Association for Laboratory Animal Science's National Meeting in Denver November 9-11, 2009 at Booth #506. To receive information about Pristima(TM) VM or Pristima(TM) visit
http://www.xybion.com.
About Xybion Medical Systems Xybion is the enterprise system partner of choice for life sciences product companies and research organizations worldwide. In addition to Pristima, Xybion provides professional services, consulting, training and validation activities to clients throughout the world. (
http://xybion.com)
Calvert Labs In Production with Pristima™
Cedar Knolls, NJ December 1, 2009
Xybion Medical Systems, the developer of Pristima™ the premier preclinical software solution on the market and a world leader in toxicology and pathology software solutions for medical and chemical research, is proud to announce that Calvert Labs has licensed, validated and placed Pristima™ into production.
Using Xybion's Standard Validation Package to accelerate its implementation and validation of Pristima, Calvert was able to leverage its internal resources to execute the validation along with Xybion's installation, training and configuration services. Calvert's project to implement Pristima is part of a larger effort to enhance its technical capabilities to further automate data collection, accelerate study reporting and to add the ability to post results to their clients utilizing near real-time technologies .
Dr. Pradip Banerjee, Xybion's Chief Executive Officer, stated "We are proud to add Calvert Labs to the Xybion client community. This is a world-class contract research organization serving the pharmaceutical and biotechnology industries and we are pleased that they have moved quickly to license, validate and place the system into production." Dr. Banerjee added, "Their strategy to take on a wider variety of studies, offer more flexibility in their study designs and to make study reports available to clients quickly, fits right in with Xybion's strategy to provide the most comprehensive, flexible, and powerful system on the market. We are tremendously satisfied that Calvert has acknowledged Xybion as its ideal information systems partner and is integrating the Pristima preclinical solution into its full array of products and services. "
Allan Reiss, CEO of Calvert Labs, remarked that "Our business differentiator is to offer clients a customized, responsive and proven approach to preclinical services. Xybion's Pristima solution fit right in with our strategy." Jeffrey Pallman, Associate Director of Toxicology, also noted: "We take pride in our track record in this industry. None of our programs have ever encountered problems at any regulatory agency because of program design, performance, or data collection. We selected Xybion as a partner after careful consideration of this legacy in the market."
After extensive research to improve its ability to bring near-real time data to our customerss, Calvert selected Xybion's Pristima solution to manage its general toxicology data as well as licensing Xybion's Standard Validation Package. Additionally, Calvert contracted Xybion to provide a full suite of professional services in order to achieve a tailored solution to match Calvert's needs.
About Calvert Labs:
Calvert Laboratories provides contract services to pharmaceutical and biotechnology companies that will generate data and information necessary to file any regulatory submission with international government health service regulatory bodies. Calvert Labs services include acute, subchronic, chronic toxicology and carcinogenicity evaluations, safety pharmacology, discovery pharmacology, telemetry, pharmacokinetic studies, immunology and immunotoxicology. Calvert Labs
About Xybion Medical Systems:
Xybion is the enterprise system partner of choice for life sciences product companies and research organizations worldwide. In addition to Pristima, Xybion provides professional services, consulting, training and validation activities to clients throughout the world. Xybion Medical Systems
